Cited by — Sodium zirconium cyclosilicate compared with potassium restriction for hyperkalemia management in type 2 diabetes: The SILVERSTAR trial | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Sodium zirconium cyclosilicate compared with potassium restriction for hyperkalemia management in type 2 diabetes: The SILVERSTAR trial.
No admitted local citation edges point to this work yet.
